What the review is
Xinli Zhang and Mengjie Dong of Hangzhou Stomatology Hospital in China published a narrative review in Frontiers in Dental Medicine (volume 7, 2026; received 8 August, accepted 13 September, published 25 September 2026, doi:10.3389/fdmed.2026.1962311; open access). Their subject is decellularized dental pulp extracellular matrix, or DPECM: pulp tissue stripped of cells and nuclear material while trying to keep the native scaffold, its collagens, glycosaminoglycans, and matrix-bound growth factors. The pitch for the material is that a blood-clot-based regenerative endodontic procedure often leaves tissue that does not closely resemble normal pulp, and a pulp-derived matrix might guide host cells toward real pulp biology instead. The authors searched PubMed from inception to 31 July 2026, screened reference lists, and retained 101 articles for narrative synthesis. They state the protocol was not registered as a systematic review, that study heterogeneity ruled out a meta-analysis, and that they received no funding and used no generative AI in the manuscript.
What the evidence actually shows
The review sorts the field by evidence level, and the pattern is consistent: characterization work, cell culture, ectopic implantation, then a thin top layer of orthotopic animal studies. On processing, the authors stress that decellularization is never neutral. The familiar screening benchmark, less than 50 ng of double-stranded DNA per milligram of dry matrix with fragments under 200 base pairs and no visible nuclei, is a cleanup check, not proof that the material is sterile, safe, or potent. In bovine pulp, limited exposure to Triton X-100 and trypsin/EDTA without SDS retained more glycosaminoglycans than harsher protocols, and the review notes there are very few direct, well-controlled comparisons between processing protocols. On biology, DPECM preparations have been associated with dental pulp stem cell adhesion, migration, and odontogenic marker expression, plus angiogenic, neural-marker, and macrophage-modulating outcomes, but the review repeatedly flags that marker staining for DSPP, DMP1, or beta III-tubulin does not demonstrate a polarized odontoblast layer, perfused vessels, or restored sensation. A 2024 systematic review it cites examined 17 animal studies of decellularized-matrix scaffolds from multiple tissue sources and found high risk of bias and protocols too different for quantitative comparison.
The strongest result and its limit
The best evidence the review identifies is a 2026 orthotopic beagle study of porcine DPECM hydrogel, which reported more pulp-like tissue than collagen or bleeding-based controls, with dentinogenic, vascular-marker, and neural-marker outcomes. Its limits are stated plainly in the review’s own evidence table: the endpoints are marker-based, and follow-up was 90 days. A separate porcine DPECM study in dog root canals showed cell entry with pulp and vascular markers but was small with short follow-up. On mechanisms, the review names one candidate worth watching: a comparative omics study identified tenascin-C as an abundant DPECM component and used Notch-pathway inhibition to support a possible tenascin-C/Notch contribution to odontoblast differentiation. The authors’ own caveat is that this rests on limited evidence, has not been independently replicated, and should not be treated as an established feature of the material. YAP/TAZ-Hippo and Wnt/beta-catenin involvement is supported mainly by in vitro work with cell-deposited, not tissue-derived, matrix.
The gap that matters
The review’s most load-bearing sentence is a negative one: as of 31 July 2026, it identified no published human clinical study directly evaluating a DPECM-based therapeutic product for pulp-dentin regeneration. Human histology after conventional regenerative endodontic procedures is the cautionary backdrop. Tissue that fills a canal after treatment is often fibrous connective tissue, cementum-like, or bone-like rather than rebuilt pulp; electron microscopy of one tooth 16 years after treatment confirmed that intracanal tissue can persist for a long time without reproducing normal pulp architecture. The review also separates cell-deposited matrix made by DPSCs or SHED from true tissue-derived DPECM, and combination products carrying exosomes or cells from the acellular matrix itself, arguing that effects of the full formulation should not be credited to DPECM alone. Its closing self-assessment is that the certainty of the literature remains predominantly preclinical and moderate to low.
What it changes
For the pulp and dentine repair program, the review sharpens a distinction the program page already makes: the route with human data is cell grafting, exemplified by the Xuan et al. randomized trial of autologous pulp stem cell implantation in immature incisors, while the acellular matrix route, including DPECM hydrogels, has not reached a first human study. That ordering matters for expectations: a cell-free pulp matrix is easier to manufacture and regulate in some ways, but on this record it is behind, not ahead. The review also notes that decellularized tooth-bud matrix can guide tooth-like development, a line of work adjacent to the bioengineered tooth germ program, while warning that this should not be confused with regeneration of adult pulp. No press coverage of this review exists as of 28 September 2026, so there is no circulating claim to correct here; the risk to watch is the broader habit of calling any marker-positive intracanal tissue a regenerated pulp, which this review explicitly argues against.
Provenance: grounded in the full text of Zhang, Xinli, and Dong, Mengjie (2026), Frontiers in Dental Medicine 7, published 25 September 2026, doi:10.3389/fdmed.2026.1962311, retrieved from the publisher’s open-access full text on 28 September 2026; authors, dates, and volume confirmed against the article’s embedded metadata. See /method/.